# Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance

> **NCT02467010** · PHASE2 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 73 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Bortezomib
- **DRUG:** Cyclophosphamide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02467010
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2015-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02467010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02467010, "Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02467010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*